Finoriq research workspace
Schrodinger, Inc. (SDGR) Historical Metrics
Schrödinger, Inc. develops physics-based computational platform that enables discovery of novel. Review SDGR valuation ratios, fundamentals, and filing metrics on Finoriq.
Company Snapshot
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
- Company
- Schrodinger, Inc. (SDGR)
- Ticker
- SDGR
- Market Cap
- $1.1B
- Latest Price
- $15.19
- Industry
- Biotech & Pharma
Schrodinger, Inc. (SDGR) Current Valuation Metrics
Static valuation preview for Schrodinger, Inc. (SDGR). Market data retrieved 2026-07-08. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/SMarket cap divided by latest TTM revenue. | 4.7x | Revenue | TTM Q1 2026 |
| Earnings YieldLatest TTM net income divided by market cap. | -8.6% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -12.1% | Operating Cash Flow | TTM Q1 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 3.82x | Stockholders' Equity | Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.